PRIA Logo™
114-hr-6174114th Congress

Closing Loopholes for Orphan Drugs Act

Sponsored By: Representative Welch, Peter [D-VT]

Unknown

Summary

Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Welch, Peter [D-VT]

VT • D

Cosponsors

  • Rep. Griffith, H. Morgan [R-VA-9]

    VA • R

    Sponsored 9/27/2016

  • Rep. Harper, Gregg [R-MS-3]

    MS • R

    Sponsored 11/17/2016

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation